Sernova Biotherapeutics Investor Relations Material

Sernova Corp is a biotechnology company focused on developing cell therapy solutions for the treatment of chronic diseases, including diabetes, hemophilia, and thyroid disorders. The company’s lead technology, the Cell Pouch System, is an implantable device designed to house therapeutic cells that can produce essential proteins or hormones, potentially offering a functional cure for diseases such as type 1 diabetes. The company is headquartered in London, Canada, and its shares are listed on the TSX and OTCQB.